Stephens J W, Krause A H, Peterson C A, Bass J J, Hartman J E, Salomon N W, Ward W K
Division of Endocrinology, Good Samaritan Hospital and Medical Center, Portland, OR.
Ann Thorac Surg. 1988 May;45(5):544-7. doi: 10.1016/s0003-4975(10)64529-8.
To assess the impact of glucose-containing priming solutions on plasma glucose level in diabetic patients during and after coronary artery bypass graft surgery, we studied 50 diabetic patients and 10 nondiabetic patients who underwent bypass graft surgery. Glucose-containing priming solutions profoundly elevated plasma glucose levels during and after bypass graft surgery. In diabetic patients who received glucose primes, intraoperative peak plasma glucose levels averaged 696 +/- 48 mg/dl as compared with 341 +/- 17 mg/dl in diabetic patients who received nonglucose primes (p less than 0.001). Despite an insulin infusion, diabetic patients underwent a much slower decline in plasma glucose levels postoperatively over a 2-hour period than did nondiabetics (who did not receive an insulin infusion). We conclude that during and immediately after coronary artery bypass surgery in diabetic patients, it is desirable to avoid administration of glucose-containing priming solutions, since such solutions profoundly elevate plasma glucose levels.
为评估含葡萄糖预充液对糖尿病患者冠状动脉搭桥手术期间及术后血浆葡萄糖水平的影响,我们研究了50例接受搭桥手术的糖尿病患者和10例非糖尿病患者。含葡萄糖预充液在搭桥手术期间及术后显著升高了血浆葡萄糖水平。接受葡萄糖预充的糖尿病患者术中血浆葡萄糖峰值平均为696±48mg/dl,而接受非葡萄糖预充的糖尿病患者为341±17mg/dl(p<0.001)。尽管输注了胰岛素,但糖尿病患者术后2小时内血浆葡萄糖水平下降速度比未输注胰岛素的非糖尿病患者慢得多。我们得出结论,在糖尿病患者冠状动脉搭桥手术期间及术后即刻,应避免使用含葡萄糖预充液,因为此类溶液会显著升高血浆葡萄糖水平。